Advent France Biotechnology
Investor profile
Venture capital
Advent France Biotechnology has backed 4 European tech companies across 4 funding rounds between 2019 and 2021, joining rounds totalling €34M. Most active in Healthtech. Data as of Nov 2026.
Deals
4
distinct rounds
Companies
4
backed
Active span
2019–2021
3 yrs
Total round €
€34M
sum of rounds joined
Deals by year
distinct rounds / yearAdvent France Biotechnology — deals by year — interactive chart.
Data table
| Advent France Biotechnology — deals by year | |
|---|---|
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 2 |
Top sectors
by dealsAdvent France Biotechnology — top sectors — interactive chart.
Data table
| Advent France Biotechnology — top sectors | |
|---|---|
| Healthtech | 4 |
Stages
by dealsAdvent France Biotechnology — stages — interactive chart.
Data table
| Advent France Biotechnology — stages | |
|---|---|
| Seed | 2 |
| Series A | 1 |
| Other | 1 |
Countries
by dealsAdvent France Biotechnology — countries — interactive chart.
Data table
| Advent France Biotechnology — countries | |
|---|---|
| Spain | 2 |
| Belgium | 1 |
| France | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared roundsPortfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Agomab Therapeutics | Belgium | 1 | €21M |
| Integra Therapeutics | Spain | 1 | €4.5M |
| Arthex Biotech | Spain | 1 | €4.3M |
| Agalaia Therapeutics | France | 1 | €4.0M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Agomab Therapeutics | Series A | €21M | 2019-04 |
| Integra Therapeutics | Other | €4.5M | 2021-12 |
| Arthex Biotech | Seed | €4.3M | 2020-07 |
| Agalaia Therapeutics | Seed | €4.0M | 2021-09 |